Advanced Life Sciences Holdings, Inc., Wyeth Unit in Pact for Pneumonia Drug

October 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Oct 1 (Reuters) - Advanced Life Sciences Holdings Inc said a unit of Wyeth bought a 4.9 percent stake in the biopharmaceutical company as part of an agreement related to antibiotic cethromycin, sending its shares up 36 percent.

Twitter
LinkedIn
Facebook
Email
Print

Alliances